Triangle Pharmaceuticals (VIRS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Triangle Pharmaceuticals (VIRS)

VIRS 40.03

0.0%

Oct 10 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: (no name provided) who wrote (7)	7/1/1997 12:26:00 PM
From: (no name provided)	of 34

More shares out and insiders filing. Today Triangle bought a protease inhibitor and other assets of privately held Avid. Potential for 2.5 million more shares out the door. Expenses will increase. On 6/24, numerous venture capitalists and other insiders have filed 144s to sell stock. By my calculations, VIRS will have 20 million shares out for a market cap of $500 million. Not bad for company with no products and nothing nearing the market till 2000. Kafka666

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next